PET scan study for metastatic invasive lobular breast cancer
Treatments studied
Part of Cancer, Skin clinical trials.
This study tests whether a special PET scan can better detect invasive lobular breast cancer that has spread. It may help doctors see the cancer more clearly and guide treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman over 18 years old
- You have been diagnosed with invasive lobular breast cancer that has spread to other parts of the body
- You are able to make your own decisions about joining the study
- You are not pregnant or breastfeeding
- You can undergo PET/CT imaging without any medical issues
- Your liver and kidney function tests are within normal limits (bilirubin and creatinine not elevated more than 1.5 times normal)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of PET scan using a special tracer (FAPI) to find cancer spread in people with lobular breast cancer when the standard scan was not clear. The goal is to see if this scan can spot more metastatic lesions, which may help guide treatment.
This study tests a new imaging agent (18F-FAPI-04) for PET scans to see if it can better detect breast cancer or its spread. It may help doctors find tumors more clearly.
This trial tests whether a special PET/CT scan using a tracer called FAPI can better detect if breast cancer has spread to lymph nodes under the arm after neoadjuvant treatment. If successful, it could guide more precise surgery and avoid unnecessary lymph node removal.
This trial tests a new PET scan (called FFNP) to see if it can find which breast cancers stop responding to hormone therapy early. It's for people with advanced hormone-receptor-positive breast cancer who are starting a new endocrine treatment.
This study uses a special PET scan (68Ga FAPI) to check if lymph nodes under the arm still have cancer after you finish pre-surgery treatment. It helps doctors see how well the treatment worked before you have surgery.
This trial compares two types of PET scans to see which one better detects ER-positive breast cancer. The results could help doctors choose the best scan for tracking your cancer.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.